Shareholder Alert - The M&A Class Action Firm Announces an Investigation of BioHaven Pharmaceutical Holding Company Ltd. - BHVN
- 81
PR Newswire
NEW YORK, May 13, 2022
NEW YORK, May 13, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating BioHaven Pharmaceutical Holding Company Ltd. (BHVN), relating to its proposed merger with Pfizer Inc. Under the terms of the agreement, BHVN shareholders will receive 0.5 shares of New Biohaven and $148.50 in cash per share. Click here for more information: http://monteverdelaw.com/case/biohaven-pharmaceutical-holding-company-ltd. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in BHVN and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert---the-ma-class-action-firm-announces-an-investigation-of-biohaven-pharmaceutical-holding-company-ltd---bhvn-301547372.html
SOURCE Monteverde & Associates PC
PR Newswire è un'agenzia stampa statunitense con sede a New York[1][2], specializzata nella stesura e diffusione di comunicati stampa.
- KuCoin annuncia un lancio di gratitudine da 10 milioni di dollari in KCS e BTC per il sostegno della community
- ACE Money Transfer e Bank AL Habib collaborano nuovamente per dare potere ai pakistani all'estero e rafforzare l'economia del Pakistan durante il Ramadan
- ACE Money Transfer annuncia la sua attesissima campagna Salam Bangladesh con premi più cospicui per il Ramadan
- Vent'anni dopo l'IPO, il valore di mercato di Weichai Power aumenta di 30 volte, distribuendo dividendi per 28 miliardi di RMB
- ChainUp rafforza la posizione di sicurezza con l'acquisizione della certificazione SOC 2 Type 2
- Bybit espande gli orizzonti del trading con le opzioni Solana